Veriheal

APRIL 11, 2022

Cannabis, despite being widely available for medical and recreational consumers across the United States, remains one of the most understudied plants. federal government is granting a handful of American companies the option to cultivate and study cannabis for medical research purposes. Drug Enforcement Agency (DEA).

Pharmaceutical 104

Pharmaceutical Research and Development DEA Clinical Trials 104

Cannabis Law Report

NOVEMBER 22, 2019

MMJ International Holdings, the premier medical cannabis research company, announced that it has received DEA approval to ship THC and CBD from Canada. MMJ International Holdings is developing oral drug products from natural whole plant extract derivatives from the marijuana plant containing THC and CBD.

DEA 66

DEA Clinical Trials THC Research and Development 66

MJ Business Attorneys

JUNE 29, 2018

Epidiolex is the first drug the FDA has approved that contains a substance derived from marijuana, and it is also the first drug approved by the FDA to be used to treat patients with Dravet syndrome. Moreover, the ball is in the Drug Enforcement Agency’s (DEA) court. On Monday, the U.S.

DEA 113

DEA CBD Pharmaceutical Research and Development 113

Cannabis Law Report

MAY 29, 2022

Earlier this month, Senators Brian Schatz (D-HI) and Cory Booker (D-NJ) sent a letter to the National Institutes of Health (NIH) and the Food and Drug Administration (FDA) urging both agencies to advance research on the therapeutic effects of psychedelic drugs. [1] Recent Regulatory Developments. Challenges.

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

SpeedWeed

JULY 23, 2021

Denver is expanding Alzheimer’s research through the efforts of local company MedPharm. . The company plans to move forward with research efforts through a special Schedule I Researcher Licenses given specifically to the company by the Drug Enforcement Administration. Denver Company Moves Forward with Research License .

Clinical Trials 52

Clinical Trials Research and Development DEA Cannabinoids 52

The Blunt Truth

SEPTEMBER 10, 2021

Welcome back to The Week in Weed, your Friday look at what’s happening in the world of legalized marijuana. We have an update on New York’s cannabis agencies. South Dakota says no to medical cannabis home grow. Nevada will open cannabis lounges in 2022. More research means a lot more product. and finally.

Research and Development 124

Research and Development DEA Consumption State Laws 124

SpeedWeed

MARCH 21, 2021

With all the buzz surrounding Delta-8-tetrahydrocannabinol (THC) in the cannabis industry, many questions circulate around what the up-and-coming cannabinoid is, where it comes from, and its legal status. It produces some psychotropic effects that are less potent than Delta-9, the primary form of THC found in cannabis.

Research and Development 52

Research and Development Hydroponic DEA Cannabinoids 52

FloridaMarijuana.net

JULY 8, 2018

5 cannabis strains to treat PTSD? The National Academies of Sciences reports that PTSD is a stressor-related disorder which develops as a result of a patient’s exposure to a traumatic event. Medical marijuana can contribute to a patient’s overall health. 5 cannabis strains to treat PTSD: 1. Food and Drug Administration.

Strains 190

Strains Indica Hybrid Research and Development 190

United Patients Group

APRIL 3, 2023

Introduction A cannabis ‘prescription’ is written by a doctor to be dispensed at a pharmacy (i.e. CVS, Walgreens, etc) as medical marijuana. Although both are legal under state law, there are currently 29 states with legislation allowing for medical cannabis and the District of Columbia.

DEA 52

DEA Patients Conditions Cannabis 52

Cannabis Law Report

JULY 6, 2021

The Congressional Research Service (CRS) released a report which says there are “three leading markets for hemp, each based on the part of the plant used: fiber, seed/grain, and flower.” The FDA has jurisdiction over the area and hasn’t developed rules allowing for CBD products in the food supply. Marijuana Moment.

Hemp 105

Hemp CBD DEA Legalization 105

CannaMD

AUGUST 8, 2020

– because today’s post is a deep dive into everything you need to know about the most popular cannabis compound around. Let’s clear up one of the biggest sources of confusion right off the bat: CBD is a cannabis compound called cannabidiol. Researchers believe cannabis contains over 100 unique chemical compounds!

CBD 99

CBD DEA Research and Development Hemp 99

Medicinal Genomics

JULY 13, 2023

So here are just a dozen new developments, breakthroughs, and aha moments from this year’s summit that might just convince you to circle CannMed 24 on your calendar right now. the VP of Research & Development at Biopharmaceutical Research Company, Inc., But if you weren’t able to be there, you wouldn’t know that.

Research and Development 52

Research and Development Cannabinoids Medicine DEA 52

Cannabis Law Report

JULY 23, 2021

On Wednesday, July 14, 2021 Senators Chuck Schumer (D-NY), Cory Booker (D-NJ), and Ron Wyden (D-OR) released draft legislation titled the Cannabis Administration and Opportunity Act. If implemented, regulatory responsibility of cannabis would be transferred from the U.S. Draft Bill Details.

Research and Development 105

Research and Development DEA Programs State Laws 105

Canna Law Blog

JULY 17, 2020

I want to study marijuana (cannabis), peyote, MDMA, psilocybin, LSD, ayahuasca/DMT and ibogaine, to start. Q: OK, I want to study cannabis. Q: What’s so hard about cannabis? A: Most cannabis research applications are ignored, or swatted away after being ignored and litigated and ignored some more.

DEA 85

DEA Research and Development Therapy Banking 85

SpeedWeed

AUGUST 11, 2021

MAPS, The Multidisciplinary Association for Psychedelic Substances, was awarded a $12,979,050 million grant from the state of Michigan to fund a study on PTSD and cannabis on August 10. This grant enables more rigorous study, overseen by the FDA, which may lead to cannabis flower becoming prescribable medicine someday.

Clinical Trials 52

Clinical Trials Research and Development Pharmaceutical DEA 52

Veriheal

AUGUST 31, 2020

Add onto that the difficulty of these unprecedented times, as a minority-owned business, we’re making it our priority to pay it forward and invest in the future leaders of cannabis who will break barriers and pave the way for innovation in this burgeoning industry. . Veriheal’s Innovation in Cannabis Scholarship 2020 Winners .

Research and Development 117

Research and Development Education Agriculture Patients 117

Cannabis Law Report

AUGUST 12, 2022

Marijuana Moment report on some of the panels being proposed for 2023…… Voting is now open for the public to decide which panels will make the stage at next year’s South By Southwest (SXSW) festival—and there are about 100 marijuana- and psychedelics-related proposals to pick from. Is cannabis actually. Green or not?

Research and Development 52

Research and Development Events Topical Policy 52

SpeedWeed

MARCH 21, 2021

With all the buzz surrounding Delta-8-tetrahydrocannabinol (THC) in the cannabis industry, many questions circulate around what the up-and-coming cannabinoid is, where it comes from, and its legal status. It produces some psychotropic effects that are less potent than Delta-9, the primary form of THC found in cannabis.

THC 52

THC Business DEA Cannabinoids 52

SpeedWeed

MARCH 17, 2021

With all the buzz surrounding Delta-8-tetrahydrocannabinol (THC) in the cannabis industry, many questions circulate around what the up-and-coming cannabinoid is, where it comes from, and its legal status. It produces some psychotropic effects that are less potent than Delta-9, the primary form of THC found in cannabis.

DEA 52

DEA Cannabinoids Research and Development THC 52

Cannabis Law Report

JANUARY 23, 2020

Cannabis Catalysts write by way of an introduction. “After taking the first steps towards the liberalization of hemp cultivation over the course of the last few years, at the end of 2018 Thailand’s government decided to legalize medical cannabis as the first Southeast Asian country. CC INSIGHTS THAILAND MEDICAL CANNABIS.

Research and Development 59

Research and Development Oil Cultivation DEA 59

Cannabis Law Report

OCTOBER 31, 2019

The first crisis point initiated by the Rule is its requirement that Labs “ must be registered by the DEA to conduct chemical analysis of controlled substances (in accordance with 21 CFR 1301.13). ” The USDA’s basis for implementing this requirement is that Labs “ could potentially handle cannabis that tests above the 0.3%

Hemp 45

Hemp DEA Concentrates THC 45

Cannabis Law Report

APRIL 21, 2022

MAPS and MAPS PBC have developed the first validated commercial synthetic process for producing multi-kilogram batches of MDMA under current Good Manufacturing Practices. The full statement. Nair, Ph.D., lead author and MAPS PBC Head of Chemistry, Manufacturing, and Controls. Berra Yazar-Klosinski, Ph.D.

Clinical Trials 52

Clinical Trials Research and Development Therapy Media 52

Freedom Leaf

DECEMBER 4, 2018

The name most associated with cannabis science is generally Israeli chemist Raphael Mechoulam, who’s credited with first isolating and identifying THC. For the first but not the last time, events on the global stage had an impact on his life, career and research. Roger Adams’ Cannabis Research Commences.

CBD 112

CBD Research and Development THC Cannabinoids 112

SMPL

AUGUST 14, 2019

The American Bar Association (ABA) adopted a resolution on Monday that calls on Congress to allow states to set their own marijuana policies and recommends rescheduling or descheduling cannabis under federal law.

Policy 40

Policy Research and Development Marijuana DEA 40

Cannabis Law Report

SEPTEMBER 20, 2019

The sale will greatly reduce the current and future burn rate of the company and allow it to focus on achieving profitability, seeking a DEA license, and implementing GMP, a set of regulations promulgated by the U.S.

Clinical Trials 40

Clinical Trials Research and Development DEA Business 40

MedicalJane

JUNE 29, 2018

The FDA announced in a press release on Monday that it had approved the “first drug comprised of an active ingredient derived from marijuana to treat rare, severe forms of epilepsy.”. None of the approved drugs contain, or are derived from, the whole cannabis plant. a Canada-based medical cannabis firm. branch of Aphria, Inc.,

Clinical Trials 53

Clinical Trials CBD DEA Research and Development 53

The Joint Blog

JUNE 4, 2021

Schedule I drugs like heroin, Lysergic Acid Diethylamide (LSD), and ecstasy are strictly regulated by the Federal Government but Marijuana has be made an exception in some states. Marijuana is also classified as a Schedule I drug but it has been given the approval for medical and recreational at some state levels. Kill cancer cells.

Conditions 32

Conditions Chronic Pain Marijuana Research and Development 32

Veriheal

JUNE 24, 2021

health official reportedly slammed “ongoing federal restrictions that are inhibiting research into marijuana”. The director was spoken to regarding psychedelics and cannabis by Senator Brian Schatz during a Senate Appropriations subcommittee hearing. Check out the hearing below at the 01:40:00 mark: .

Research and Development 52

Research and Development Clinical Trials Treatment Access 52

Cannabis Law Report

JUNE 4, 2021

Dr Stuart Titus the CEO at Medical Marijuana Inc. is an industry innovator who has been involved in the growth of many companies in the cannabis industry, and started his relationship with Medical Marijuana Inc. Delta-8 could be part of this future cannabis omnibus bill or it may be left out and regulated separately.

Research and Development 105

Research and Development Seed-To-Sale Cannabinoids THC 105

Cannabis Law Report

APRIL 1, 2019

Selling dried cannabis to pharmaceutical companies as well as Cannabidiol (CBD) and Tetrahydrocannabinol (THC) extracts as soon as it is licensed, is the intention of Thailand’s tobacco authority among new measures to turn a profit on its dwindling cigarette business. TOAT, the First Thai Cannabis Money Maker.

Research and Development 40

Research and Development Pharmaceutical Clinical Trials DEA 40

Otherside Farms

AUGUST 4, 2020

Any entrepreneur looking to get onto something big should look at the opportunities that the cannabis industry offers. Concrete extraction technicians, researchers, marijuana cultivators, marketers, marijuana processors, cannabis branding, and developers will all have a place in the industry.

Business 52

Business Banking Dispensary Research and Development 52

Cannabis Law Report

SEPTEMBER 20, 2019

They write… In this week’s edition: Plans to vote on cannabis banking legislation announced in both chambers of Congress, with predictions that House will pass the SAFE Act by the end of October. DEA increases the cannabis research quota. This represents a 30 percent increase from the 2019 cannabis quota.

Vaping 40

Vaping Banking Research and Development DEA 40

The Cannigma

JULY 3, 2023

Moreover, since both cannabis and MDMA are on their way to either descheduling, decriminalization or legalization around the world, this number is likely to grow. A whopping 95% of people who use MDMA/ecstasy also consume cannabis. Nearly 1% of Americans over the age of 12 have used MDMA in the past 12 months. That’s around 2.5

Research and Development 46

Research and Development Environment THC Microdosing 46

Canna Law Blog

APRIL 22, 2020

In this global upheaval and opportunity seeking, cannabis is no exception. cannabis marketplace. cannabis markets. Companies in Europe tend to be experts in producing cannabis products, including distillates such as oil, because they have been working with legalized cannabis longer than most. customs.

Supply Chain 53

Supply Chain Research and Development Hemp DEA 53

Kind Meds (Cannabis Education Blog)

SEPTEMBER 4, 2019

Our level of interest in Arizona cannabis products can run the gamut: from infrequent enthusiast to a daily shake of the wake-and-bake. Cannabis consumers aren’t one in the same. But what’s behind the cannabis confections, concentrates, topicals, and sweet flowers that we’ve come to enjoy? It depends. Here’s why.

Dispensary 69

Dispensary Research and Development Pets Patients 69

SpeedWeed

MARCH 5, 2021

Having spent more than 25 years studying cannabis policy and scheduling, I take issue with this interpretation. Bilmoria opine: “[R]emoving cannabis from Schedule I of the CSA would mean that it could be treated as any other physician-prescribed drug. Authors Tracy Gallegos and Neville M.

Business 52

Business Policy Clinical Trials Research and Development 52

Canna Law Blog

SEPTEMBER 6, 2023

HHS officially recommended that marijuana be rescheduled from Schedule I to Schedule III of the federal Controlled Substances Act (CSA). The HHS news means that the country’s top health agency has finally conceded that cannabis has medical value, and isn’t a drug of abuse on par with fentanyl or heroin.

Research and Development 112

Research and Development DEA Marijuana Pharmaceutical 112